Cite
HARVARD Citation
Abou-Alfa, G. et al. (2018). Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma. Annals of oncology. pp. 1402-1408. [Online].